Aptinyx Inc. (APTX): Price and Financial Metrics
APTX Price/Volume Stats
| Current price | $0.10 | 52-week high | $0.72 |
| Prev. close | $0.09 | 52-week low | $0.01 |
| Day low | $0.09 | Volume | 231,100 |
| Day high | $0.10 | Avg. volume | 1,317,051 |
| 50-day MA | $0.07 | Dividend yield | N/A |
| 200-day MA | $0.08 | Market Cap | 6.50M |
APTX Stock Price Chart Interactive Chart >
Aptinyx Inc. (APTX) Company Bio
Aptinyx Inc. develops therapeutics for neurological disorders. The company is focused on the development of drugs that interact with the NMDA receptor, and the company says it will use the funds to advance drugs for chronic pain, post-traumatic stress disorder (PTSD) and cognitive impairment in Parkinson’s disease. The company was founded in 2015 and is based in Evantson, Illinois.
APTX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 9.77% |
| 3-year | -96.25% |
| 5-year | -97.26% |
| YTD | 4.17% |
| 2023 | -66.35% |
| 2022 | -89.31% |
| 2021 | -22.83% |
| 2020 | 1.17% |
| 2019 | -79.32% |
Continue Researching APTX
Want to see what other sources are saying about Aptinyx Inc's financials and stock price? Try the links below:Aptinyx Inc (APTX) Stock Price | Nasdaq
Aptinyx Inc (APTX) Stock Quote, History and News - Yahoo Finance
Aptinyx Inc (APTX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...